Researchers at the Collagen Research Institute (CRI) in Kiel, Germany, have demonstrated the stimulating effect of special bioactive collagen peptides (FORTIGEL®) in the context of cell experiments. In September 2009 the CRI presented its research findings at the congress of the Osteoarthritis Research Society International (OARSI) in Montreal. The investigations of the CRI provide an explanation for the findings of a joint clinical trial carried out by Harvard Medical School and Tufts Medical Center – likewise presented at the congress. With the aid of special imaging (MRI) techniques this clinical trial demonstrated that FORTIGEL® stimulated cell metabolism in the knee-joint cartilage and promotes the regeneration of cartilage tissue.

FORTIGEL® honored as an outstanding pioneer development for healthy joints – excellent market chances for applications in nutrition and medicine.